June 2021

Take-away diagnostics: Delivering the future?

After a rise in at-home tests and a fall in non-COVID-related hospital attendances during the pandemic, will a new era of diagnostics be ushered in as we return to normality? We look at the evidence.

Unintended consequences

Computational biologist Gregorio Alanis- Lobato highlights the need for greater awareness of and further research into the effects of CRISPR-Cas9 genome editing.

The big question: multidisciplinary working

This month we ask: “What is the future of multidisciplinary working?”

The evolution of quality assessment

In 2011, UK NEQAS Cellular Pathology Technique (CPT) carried out tests across four schemes – it now covers 12 schemes with two in the pipeline. We hear from Chantell Hodgson, UK NEQAS CPT Scheme Manager.

Tech news: June

This month's top tech news stories

“Tumour-uninformed” blood test

A team of scientists has evaluated the first “tumour-uninformed” test that detects cancer DNA circulating in the blood of patients following treatment.

Ultrasonically oscillating biopsy needles

Modifying a biopsy needle to vibrate rapidly at 30,000 times per second improves yields and could mean potentially a less painful experience for patients.

The British Journal of Biomedical Science: Issue 3 2021 synopsis

Deputy Editor Nigel Brown provides a brief glimpse of the articles on offer in the third issue of 2021.

Blurring boundaries: Ethics and artificial intelligence

With artificial intelligence becoming ever more prominent in biomedical labs and research, biomedical scientist turned ethicist Sarah E Carter looks at the pressing issues.

New histopathology method

A recent advance in histopathology eliminates the need for chemical staining and enables high-resolution imaging of thick tissue sections.

A new era

Sarah May, Deputy Chief Executive of the IBMS, welcomes the new Chief Executive to the Institute.

Top